A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Valérie Paradis(Inserm), Alessio Aghemo, Maria Grazia Rumi(University of Milan), Massimo Colombo(University of Milan), Guido Ronchi(University of Milan), Maria Francesca Donato(University of Milan)
Cited by 404
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539